Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Researchers track Long-Term safety of weekly nerve disorder treatment

NCT ID NCT07188844

Summary

This study follows up on a previous trial to check the long-term safety of a weekly injection called batoclimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder. About 108 participants who finished the earlier study will receive the injection for up to one year while researchers monitor for side effects. The main goal is to see how well people tolerate this treatment over a longer period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Site Number - 1601

    Austin, Texas, 78759, United States

  • Site Number - 1610

    Charlotte, North Carolina, 28207, United States

  • Site Number - 1611

    Nicholasville, Kentucky, 40356, United States

  • Site Number - 1617

    Ormond Beach, Florida, 32174, United States

  • Site Number - 1621

    New Haven, Connecticut, 06519, United States

  • Site Number - 3201

    Katowice, Silesian Voivodeship, 40-123, Poland

  • Site Number - 3206

    Lublin, Lublin Voivodeship, 20-701, Poland

  • Site Number - 3207

    Poznan, Greater Poland Voivodeship, 61-731, Poland

  • Site Number - 3208

    Krakow, Lesser Poland Voivodeship, 30-688, Poland

  • Site Number - 3209

    Krakow, Lesser Poland Voivodeship, 31-202, Poland

  • Site Number - 3210

    Lublin, Lublin Voivodeship, 20-064, Poland

  • Site Number - 4680

    Leuven, Vlaams Brabant, 3000, Belgium

  • Site Number - 6305

    Bologna, Emilia-Romagna, 40139, Italy

  • Site Number - 6307

    Milan, Lombardy, 20132, Italy

  • Site Number - 6309

    Rome, Lazio, 00133, Italy

  • Site Number - 6341

    Pátrai, Achaïa, 265 04, Greece

  • Site Number - 6344

    Athens, Attica, 115 25, Greece

  • Site Number - 6347

    Larissa, 41110, Greece

  • Site Number - 6702

    Leipzig, Saxony, 04103, Germany

  • Site Number - 7750

    Buenos Aires, C1199ABB, Argentina

  • Site Number - 7751

    Rosario, Santa Fe Province, S2000DTP, Argentina

  • Site Number - 7752

    San Miguel de Tucumán, T4000AXL, Argentina

  • Site Number - 7753

    Rosario, Santa Fe Province, S2000BZL, Argentina

  • Site Number - 8400

    Constanța, 900591, Romania

  • Site Number - 8403

    Timișoara, Timiș County, 300736, Romania

  • Site Number - 8501

    Belgrade, 11000, Serbia

  • Site Number - 8603

    Prešov, 081 81, Slovakia

  • Site Number - 9100

    Ribeirão Preto, São Paulo, 14048-900, Brazil

  • Site Number - 9101

    Curitiba, Paraná, 81210-310, Brazil

  • Site Number - 9103

    Brasília, Federal District, 70200-730, Brazil

Conditions

Explore the condition pages connected to this study.